Nymox Pharmaceutical annual capital expenditures (capex)
2016
2018
2019
2020
2021
2022
2023
2024
Nymox Pharmaceutical Capital Expenditures (CapEx) Growth & History (NYMXF)
Nymox Pharmaceutical's capital expenditures (capex) was $0 for fiscal 2024.
View full Nymox Pharmaceutical company overviewNymox Pharmaceutical annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | $0 | −$3,000 | — |
| 2023 | 2023-12-31 | $3,000 | $3,000 | — |
| 2022 | 2022-12-31 | $0 | −$6,000 | — |
| 2021 | 2021-12-31 | $6,000 | −$7,000 | −53.85% |
| 2020 | 2020-12-31 | $13,000 | $13,000 | — |
| 2019 | 2019-12-31 | $0 | −$36,000 | — |
| 2018 | 2018-12-31 | $36,000 | — | — |
| 2016 | 2016-12-31 | $2,000 | — | — |
Nymox Pharmaceutical quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | $0 | $0 | — |
| Q3 2023 | 2023-09-30 | $0 | $0 | — |
| Q2 2023 | 2023-06-30 | $0 | $0 | — |
| Q1 2023 | 2023-03-31 | $3,000 | $3,000 | — |
| Q4 2022 | 2022-12-31 | $0 | −$4,000 | — |
| Q3 2022 | 2022-09-30 | $0 | $0 | — |
| Q2 2022 | 2022-06-30 | $0 | $0 | — |
| Q1 2022 | 2022-03-31 | $0 | −$2,000 | — |
| Q4 2021 | 2021-12-31 | $4,000 | −$8,000 | −66.67% |
| Q3 2021 | 2021-09-30 | $0 | −$1,000 | — |
| Q2 2021 | 2021-06-30 | $0 | $0 | — |
| Q1 2021 | 2021-03-31 | $2,000 | $2,000 | — |
| Q4 2020 | 2020-12-31 | $12,000 | — | — |
| Q3 2020 | 2020-09-30 | $1,000 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
Nymox Pharmaceutical capital expenditures (capex) trends
Over the last five fiscal years, Nymox Pharmaceutical's capital expenditures (capex) increased from $0 to $0, a change of $0. The latest reported quarter, Q4 2023, shows $0.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nymox Pharmaceutical source filings ↗